Charles River Laboratories (CRL) support and resistance · rev $2.00B
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
This page maps Charles River Laboratories (CRL) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
CRL currently screens at market cap $7.78B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CRL 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CRL quote page for the session range and the stock page for the full model.
Not investment advice.